Conclusions
stroke, bleeding, statin-associated
ADVERSE EVENTS, STROKE, BLEEDING
Without increasing bleeding and statin-associated adverse events, intensive rosuvastatin therapy plus 7-day DAPT significantly reduced the risk of recurrent stroke, especially for subgroups with high-risk factors. 